|
🐜
|
Initial genome sequencing and analysis of multiple myeloma
49 auth.
M. Chapman,
M. Lawrence,
J. Keats,
K. Cibulskis,
C. Sougnez,
Anna C. Schinzel,
C. Harview,
Jean-Philippe Brunet,
G. Ahmann,
Mazhar Adli,
K. Anderson,
K. Ardlie,
D. Auclair,
A. Baker,
P. Bergsagel,
...
B. Bernstein,
Y. Drier,
R. Fonseca,
S. Gabriel,
C. Hofmeister,
S. Jagannath,
A. Jakubowiak,
A. Krishnan,
J. Levy,
T. Liefeld,
S. Lonial,
Scott Mahan,
Bunmi Mfuko,
S. Monti,
L. Perkins,
R. Onofrio,
Trevor J Pugh,
S. Vincent Rajkumar,
A. Ramos,
D. Siegel,
A. Sivachenko,
S. Trudel,
R. Vij,
Douglas Voet,
W. Winckler,
T. Zimmerman,
J. Carpten,
Jeff Trent,
W. Hahn,
L. Garraway,
M. Meyerson,
E. Lander,
G. Getz,
T. Golub
|
10 |
2011 |
10
🐜
|
|
🐢
|
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
30 auth.
J. Keats,
R. Fonseca,
M. Chesi,
R. Schop,
A. Baker,
W. Chng,
S. V. Van Wier,
R. Tiedemann,
C. Shi,
M. Sebag,
E. Braggio,
T. Henry,
Yuan-Xiao Zhu,
Homer Fogle,
T. Price-Troska,
...
G. Ahmann,
Catherine M. Mancini,
L. Brents,
Shaji K. Kumar,
P. Greipp,
A. Dispenzieri,
B. Bryant,
G. Mulligan,
L. Bruhn,
M. Barrett,
R. Valdez,
Jeff Trent,
A. Stewart,
J. Carpten,
P. Bergsagel
|
10 |
2007 |
10
🐢
|
|
🐜
|
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
23 auth.
R. Fonseca,
P. Bergsagel,
J. Drach,
J. Shaughnessy,
N. Gutiérrez,
A. Stewart,
G. Morgan,
B. Ness,
M. Chesi,
S. Minvielle,
...
A. Neri,
B. Barlogie,
W. Kuehl,
P. Liebisch,
F. Davies,
S. Chen‐Kiang,
B. Durie,
Ruben D Carrasco,
O. Sezer,
T. Reiman,
L. Pilarski,
H. Avet‐Loiseau,
H. Avet-Loiseau
|
9 |
2009 |
9
🐜
|
|
🐜
|
The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee.
72 auth.
E. Campo,
E. Jaffe,
J. Cook,
L. Quintanilla‐Martinez,
S. Swerdlow,
K. Anderson,
P. Brousset,
L. Cerroni,
L. de Leval,
S. Dirnhofer,
A. Dogan,
A. Feldman,
F. Fend,
J. Friedberg,
P. Gaulard,
...
P. Ghia,
S. Horwitz,
R. King,
G. Salles,
J. San-Miguel,
J. Seymour,
S. Treon,
J. Vose,
E. Zucca,
R. Advani,
S. Ansell,
W. Au,
C. Barrionuevo,
P. Bergsagel,
W. Chan,
J. Cohen,
A. Davies,
B. Falini,
I. Ghobrial,
J. Goodlad,
J. Gribben,
E. Hsi,
B. Kahl,
W. Kim,
Shaji K. Kumar,
A. LaCasce,
C. Laurent,
G. Lenz,
J. Leonard,
M. Link,
A. López-Guillermo,
M. Mateos,
E. Macintyre,
A. Melnick,
F. Morschhauser,
S. Nakamura,
M. Narbaitz,
A. Pavlovsky,
S. Pileri,
M. Piris,
B. Pro,
S. Rajkumar,
S. Rosen,
B. Sander,
L. Sehn,
M. Shipp,
Sonali M. Smith,
L. Staudt,
C. Thieblemont,
T. Tousseyn,
W. Wilson,
T. Yoshino,
P. Zinzani,
M. Dreyling,
D. Scott,
J. Winter,
A. Zelenetz
|
9 |
2022 |
9
🐜
|
|
🐢
|
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines.
22 auth.
Shaji K. Kumar,
J. Mikhael,
F. Buadi,
D. Dingli,
A. Dispenzieri,
R. Fonseca,
M. Gertz,
P. Greipp,
S. Hayman,
R. Kyle,
...
M. Lacy,
J. Lust,
C. Reeder,
V. Roy,
S. Russell,
K. D. Short,
A. Stewart,
T. Witzig,
S. Zeldenrust,
R. Dalton,
S. Rajkumar,
P. Bergsagel
|
9 |
2009 |
9
🐢
|
|
🐜
|
Genetics and Cytogenetics of Multiple Myeloma
18 auth.
R. Fonseca,
B. Barlogie,
R. Bataille,
C. Bastard,
P. Bergsagel,
M. Chesi,
F. Davies,
J. Drach,
P. Greipp,
I. Kirsch,
...
W. Kuehl,
Jesús M. Hernández,
S. Minvielle,
L. Pilarski,
J. Shaughnessy,
A. Stewart,
H. Avet‐Loiseau,
H. Avet‐Loiseau
|
8 |
2004 |
8
🐜
|
|
🦁
|
Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
P. Bergsagel,
M. Chesi,
E. Nardini,
L. Brents,
S. Kirby,
W. Kuehl
|
8 |
1996 |
8
🦁
|
|
🐜
|
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.
19 auth.
G. Mulligan,
C. Mitsiades,
B. Bryant,
F. Zhan,
W. Chng,
S. Roels,
Erik Koenig,
Andrew Fergus,
Yongsheng Huang,
P. Richardson,
...
W. Trepicchio,
A. Broyl,
P. Sonneveld,
J. Shaughnessy,
P. Bergsagel,
D. Schenkein,
D. Esseltine,
A. Boral,
K. Anderson
|
8 |
2006 |
8
🐜
|
|
🐜
|
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.
27 auth.
J. Mikhael,
D. Dingli,
V. Roy,
C. Reeder,
F. Buadi,
S. Hayman,
A. Dispenzieri,
R. Fonseca,
T. Sher,
R. Kyle,
Yi Lin,
S. Russell,
Shaji K. Kumar,
P. Bergsagel,
S. Zeldenrust,
...
N. Leung,
Matthew T. Drake,
P. Kapoor,
S. Ansell,
T. Witzig,
J. Lust,
R. Dalton,
M. Gertz,
K. Stewart,
S. Rajkumar,
A. Chanan-Khan,
M. Lacy
|
8 |
2013 |
8
🐜
|
|
🐜
|
Cyclophosphamide, bortezomib and dexamethasone (CyBorD) induction for newly diagnosed multiple myeloma: High response rates in a phase II clinical trial
16 auth.
C. Reeder,
D. Reece,
V. Kukreti,
Christine I. Chen,
S. Trudel,
J. Hentz,
B. Noble,
N. Pirooz,
J. Spong,
Jesus G. Piza,
...
V. Zepeda,
J. Mikhael,
J. Leis,
P. Bergsagel,
R. Fonseca,
A. Stewart
|
8 |
2009 |
8
🐜
|
|
🐢
|
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.
14 auth.
M. Chesi,
D. Robbiani,
M. Sebag,
W. Chng,
M. Affer,
R. Tiedemann,
R. Valdez,
Stephen E. Palmer,
Stephanie S. Haas,
A. Stewart,
...
R. Fonseca,
R. Kremer,
G. Cattoretti,
P. Bergsagel
|
8 |
2008 |
8
🐢
|
|
🐜
|
Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.
10 auth.
Y. Shou,
M. Martelli,
Ana Gabrea,
Ying Qi,
L. Brents,
A. Roschke,
...
G. Dewald,
I. Kirsch,
P. Bergsagel,
W. Kuehl
|
8 |
2000 |
8
🐜
|
|
🐜
|
Genetic aberrations and survival in plasma cell leukemia
17 auth.
R. Tiedemann,
Natalia C Gonzalez-Paz,
R. Kyle,
R. Santana-Davila,
T. Price-Troska,
S. V. Wier,
W. Chng,
R. Ketterling,
M. Gertz,
K. Henderson,
...
P. Greipp,
A. Dispenzieri,
M. Lacy,
S. Rajkumar,
P. Bergsagel,
A. Stewart,
R. Fonseca
|
8 |
2008 |
8
🐜
|
